Hahnemann University Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sherman, Michael P
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
Green, Michael
RIVAL, NCT06275360: Repositioning Immunotherapy in VetArans With Lung Cancer

Recruiting
2
25
US
Nivolumab, Opdivo
VA Office of Research and Development
Non-Small Cell Lung Cancer
02/27
03/30
BELIEVE, NCT05588388: Study of Bevacizumab in Combination with Chemoimmunotherapy and Atezolizumab in Patients with Extensive Stage Small Cell Lung Cancer and Liver Metastases

Recruiting
2
39
US
Bevacizumab
Kamya Sankar, Genentech, Inc., University of Michigan, VA Ann Arbor Healthcare System
Extensive-stage Small-cell Lung Cancer, Liver Metastases
12/26
12/27
HAMMER I, NCT05169957: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial

Completed
1
2
US
Ipilimumab, Nivolumab, Stereotactic Body Radiation Therapy, SBRT
University of Michigan Rogel Cancer Center
Melanoma, Ocular, Melanoma, Cutaneous, Metastatic Melanoma, Melanoma, Mucosal, Liver Metastases
06/23
07/24
NCT05411094: Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Recruiting
1
18
Canada, US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Radiologic Examination, Radiologic Evaluation, Radiologic Exam
National Cancer Institute (NCI)
Locally Advanced Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma
09/25
09/25
NCT05430009: Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Recruiting
1
12
US
Liver SBRT, Pembrolizumab
VA Ann Arbor Healthcare System, Lungevity
Liver Metastases, Non-small Cell Lung Cancer
12/25
06/26
NCT03924219: CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Active, not recruiting
N/A
120
US
CMV T cell Immunity Assay
Vanderbilt University Medical Center, ViraCor Laboratories
Heart Transplant Infection, Kidney Transplant Infection, Liver Transplant Infection, CMV
08/24
07/25
SAMI, NCT05617898: Determining the Role of Social Reward Learning in Social Anhedonia

Recruiting
N/A
152
US
Motivational Interviewing, Nutrition Didactic Training
University of Alabama at Birmingham, University of California, Los Angeles, National Institute of Mental Health (NIMH)
Psychosis
11/27
11/27
Bradt, Joke
NCT05215353: A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Recruiting
4
350
US
Music Therapy, Cognitive Behavioral Therapy, assessments
Memorial Sloan Kettering Cancer Center, Patient-Centered Outcomes Research Institute
Survivorship
01/26
01/26
Komarnicky-Kocher, Lydia T
No trials found
Bryl, Karolina
No trials found
Rubin, Rene R
No trials found
Jacobson, Jeff
No trials found
Hendry, Mary P
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sherman, Michael P
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
Green, Michael
RIVAL, NCT06275360: Repositioning Immunotherapy in VetArans With Lung Cancer

Recruiting
2
25
US
Nivolumab, Opdivo
VA Office of Research and Development
Non-Small Cell Lung Cancer
02/27
03/30
BELIEVE, NCT05588388: Study of Bevacizumab in Combination with Chemoimmunotherapy and Atezolizumab in Patients with Extensive Stage Small Cell Lung Cancer and Liver Metastases

Recruiting
2
39
US
Bevacizumab
Kamya Sankar, Genentech, Inc., University of Michigan, VA Ann Arbor Healthcare System
Extensive-stage Small-cell Lung Cancer, Liver Metastases
12/26
12/27
HAMMER I, NCT05169957: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial

Completed
1
2
US
Ipilimumab, Nivolumab, Stereotactic Body Radiation Therapy, SBRT
University of Michigan Rogel Cancer Center
Melanoma, Ocular, Melanoma, Cutaneous, Metastatic Melanoma, Melanoma, Mucosal, Liver Metastases
06/23
07/24
NCT05411094: Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Recruiting
1
18
Canada, US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Radiologic Examination, Radiologic Evaluation, Radiologic Exam
National Cancer Institute (NCI)
Locally Advanced Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma
09/25
09/25
NCT05430009: Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Recruiting
1
12
US
Liver SBRT, Pembrolizumab
VA Ann Arbor Healthcare System, Lungevity
Liver Metastases, Non-small Cell Lung Cancer
12/25
06/26
NCT03924219: CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Active, not recruiting
N/A
120
US
CMV T cell Immunity Assay
Vanderbilt University Medical Center, ViraCor Laboratories
Heart Transplant Infection, Kidney Transplant Infection, Liver Transplant Infection, CMV
08/24
07/25
SAMI, NCT05617898: Determining the Role of Social Reward Learning in Social Anhedonia

Recruiting
N/A
152
US
Motivational Interviewing, Nutrition Didactic Training
University of Alabama at Birmingham, University of California, Los Angeles, National Institute of Mental Health (NIMH)
Psychosis
11/27
11/27
Bradt, Joke
NCT05215353: A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Recruiting
4
350
US
Music Therapy, Cognitive Behavioral Therapy, assessments
Memorial Sloan Kettering Cancer Center, Patient-Centered Outcomes Research Institute
Survivorship
01/26
01/26
Komarnicky-Kocher, Lydia T
No trials found
Bryl, Karolina
No trials found
Rubin, Rene R
No trials found
Jacobson, Jeff
No trials found
Hendry, Mary P
No trials found

Download Options